MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Costs and Expenses in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2024.
  • Maravai Lifesciences Holdings, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $234M, a 185% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $482M, a 43.8% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Costs and Expenses for 2023 was $321M, a 3.82% increase from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Costs and Expenses for 2022 was $309M, a 26.2% increase from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Costs and Expenses for 2021 was $245M, a 49% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $482M $234M +$152M +185% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $330M $82.9M +$2.38M +2.96% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $327M $83M +$6.55M +8.56% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $321M $81.3M -$14.2M -14.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $335M $82.3M +$7.92M +10.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $327M $80.5M +$18.5M +29.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $308M $76.5M -$435K -0.57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $309M $95.5M +$21.6M +29.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $287M $74.4M +$24.9M +50.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $262M $62M -$2.21M -3.44% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $265M $76.9M +$19.9M +34.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $245M $73.9M +$6.8M +10.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $238M $49.4M +$7.29M +17.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $231M $64.2M +$25.5M +65.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $205M $57M +$40.9M +253% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $164M $67.1M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $42.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $38.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $16.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.